CardioSource WorldNews | Page 13

Proven protection from
Sudden Cardiac Death
+ so much more
The LifeVest® provides
proven protection from
Sudden Cardiac Death
with a connection to your
patients’ changing cardiac
condition through the
LifeVest Network.
ZOLL

1 in 14 patients

With the LifeVest Network, you can
diagnose arrhythmic events including:

require arrhythmia
intervention while
wearing the LifeVest.

1

+
+
+
+

Sustained VT
Non-sustained VT
Atrial arrhythmias/SVT
Severe bradycardia/Asystole

Learn more at www.zoll.com/lifevestnetwork or
by contacting your LifeVest Representative today.
1. Kutyifa V, Moss AJ, Klein H, et al. Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data from the
Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation 2015; 132(17): 1613-1619.
© 2016 ZOLL Medical Corporation. ZOLL and LifeVest are registered trademarks of ZOLL Medical Corporation in the United States
and/or other countries.

20C0559 rev FI